Surgihoney™

Medical Honey Wound Gel

Surgihoney™

Surgihoney™ is a bioengineered, medical grade honey wound gel. The product is approved for use on a broad range of wounds – acute, chronic, infected. Surgihoney™ supplements the healing properties of honey with potent antimicrobial activity.

Surgihoney™ supports the body to fight infection and heal via the sustained release of safe, low levels of Reactive Oxygen™[1,2]. It has broad-spectrum activity against both Gram-positive and Gram-negative bacteria, including multi-drug resistant strains such as MRSA, Pseudomonas aeruginosa and E. coli.[3]. Laboratory testing has demonstrated superior efficacy in preventing biofilm formation compared to standard medical honeys in vitro[4].

Surgihoney™ combines the healing properties of honey with effective antimicrobial activity. Due to its sustained release of safe, low levels of Reactive Oxygen™ (RO®) it is particularly suitable for the treatment of infected wounds.

 

Key benefits

  • Wound barrier & moist healing environment
  • Effective de-sloughing agent[5]
  • Local wound nutrition[5]
  • Broad spectrum activity against bacteria and fungi[3]
  • Reduce bacterial load[5]
  • Anti-biofilm action in vitro[4]
  • Reduce inflammation & pain[5]
  • Safe to use (non-toxic)[5]
  • Improve healing[5]

Indications for Surgihoney™

  • Leg ulcers
  • Diabetic ulcers
  • Pressure ulcers
  • Surgical wounds
  • Infected wounds
  • Burns & skin grafts
  • Cuts & abrasions


Surgihoney™ is manufactured by Matoke Holdings Limited www.surgihoneyro.com.

For further information please contact the office on 01482 631606 or email info@hrhealthcare.co.uk.



References
[1] Cooke, J., Dryden, M., Patton, T., Brennan, J. and Barrett, J. (2015) The antimicrobial activity of prototype modified honeys that generate Reactive Oxygen™ species (ROS) hydrogen peroxide, 8(1).
[2] Dunnill, C., Patton, T., Brennan, J., et al. (2015) Reactive Oxygen™ species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process.
[3] Dryden, M., Lockyer, G., Kordo, S. and Cooke, J. (2014) Engineered honey: in vitro antimicrobial activity of a novel topical wound care treatment. Journal of Global Antimicrobial Resistance, 2(3).
[4] Halstead, F.D., Webber, M.A., et al. (2016) In vitro activity of an engineered honey, medical-grade honeys and antimicrobial wound dressings against biofilm-producing clinical bacterial isolates. JWC, 25(2).
[5] Dryden, M., et al. (2016) A multi-centre clinical evaluation of Reactive Oxygen™ topical wound gel in 114 wounds.